尼沃卢马布治疗与IgG4相关疾病相关的肺癌
Mari Aso1, Hiroki Suzuki1, Takafumi Aizawa1
1Department of Pulmonary Medicine, Yamagata Prefectural Central Hospital, Japan.
这项研究表明,nivolumab是一种抗编程细胞死亡蛋白-1抗体,在与低剂量类固醇结合时,可以安全地用于患有IgG4相关疾病 (IgG4-RD) 的肺癌患者.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 与免疫球蛋白G4相关的疾病 (IgG4-RD) 可以在肺癌患者中出现并发症.
- 同时的IgG4-RD和肺癌的管理需要仔细考虑治疗相互作用.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
相关概念视频
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Treatment Resistant Cancers
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
